Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

Breakthrough Drug Finerenone Now Proven to Protect the Kidneys and Heart in Millions More Patients Than Doctors Thought — Houston's CKD Patients Stand to Benefit Most

Major June 2026 studies show finerenone slows kidney disease and cuts heart failure risk even in patients without diabetes — expanding its benefit to millions. Houston has one of the highest CKD rates in Texas.

Medical Daily

Fertility Institute of Hawaii Joins Nucleus IVF+ Network as Demand for Genetic Optimization Continues to Expand

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Nucleus Genomics today announced an IVF+ partnership with the Fertility Institute of Hawaii, bringing its advanced carrier screening and embryo analysis to Hawaii's largest IVF practice.Through the collaboration, patients will gain deeper genetic insight into their embryos during IVF, including risks tied…

AAP

5 Warning Signs Your Nerves May Be Dying

What if your body was quietly warning you about a serious health problem but you didn't recognize the signs? Many people dismiss occasional tingling, muscle weakness, or unexplained pain as stress, fatigue, or simply getting older. But in some cases, these seemingly harmless symptoms may be early warning signs of…

MyLifeXP

From analysis to the latest developments in health,
read the most diverse news in one place.

A Quiet Breakthrough at ADA 2026: New Therapy Could Fill Gap for Patients Who Can't Use GLP-1 Drugs

Petrelintide emerged as a major ADA 2026 breakthrough, offering hope for patients who stop GLP-1 therapies due to nausea and GI side effects.

Medical Daily

Attorneys urge release of mosque leader, saying he's been denied diabetes care in ICE custody

Attorneys for the president of Wisconsin's largest mosque say he is being denied basic medical care for diabetes and has lost 30 pounds since he was taken into custody two months ago by U.S. Immigration and Customs Enforcement

The Independent UK

US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss market

Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients ‌with obesity, ⁠at the ⁠American Diabetes Association meeting in New Orleans.

The Economic Times

Why You're Always Exhausted Even After a Full Night's Sleep

You go to bed on time, sleep for seven to nine hours, and expect to wake up feeling refreshed. Instead, you drag yourself out of bed, reach for another cup of coffee, and spend the day feeling drained. If this sounds familiar, you're not alone. Many people experience constant tiredness…

MyLifeXP

Read news from The Economist, FT, and more,
with one subscription

Stanford Study Identifies Why Ozempic and Wegovy Don't Work in About 1 in 10 Patients

A Stanford Medicine study identifies a genetic variant in about 10% of people that may reduce response to GLP-1 drugs like Ozempic and Wegovy, offering new insight into why these widely used diabetes and weight-loss treatments fail for some patients and highlighting the future of precision medicine in Type 2…

Medical Daily

Triple-action diabetes jab shown to reduce blood sugar and body weight

Retatrutide is designed to control appetite and blood sugar but also increase body’s energy expenditure, unlike other drugs

The Guardian - UK

Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefits

Eli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoarthritis pain in adults with obesity. Patients also experienced substantial weight loss. These findings were shared at an American Diabetes Association conference. Retatrutide targets multiple hormones related to obesity and…

The Economic Times

In 26 Days, Hundreds of Thousands of LA County Residents Will Lose Medi-Cal Dental Coverage — And Most Don't Know It's Happening

Hundreds of thousands of Los Angeles Medi-Cal beneficiaries could lose dental coverage on July 1, 2026, raising concerns about worsening diabetes, oral health complications, and reduced access to preventive care.

Medical Daily

Move Over, Ozempic: Scientists Unveiled a New Diabetes Pill That Burns Fat Without Killing Your Appetite — And It Could Be a Breakthrough for Millions of Americans

Researchers at Karolinska Institutet published a study showing a new oral compound activates muscle metabolism to lower blood sugar and torch fat — without nausea, muscle loss, or the side effects plaguing GLP-1 drugs.

Medical Daily

'I Was Chest-Bumped by Police': Lead Journal Editor Thrown Out of Diabetes Conference for Criticising Trump's Research Cuts

Five scientists were removed from a diabetes conference for distributing an editorial criticising the Trump administration's biomedical science policies, leading to a ban from the event.

International Business Times UK

In 1889, a physician noticed a sweet urine clue and helped point medicine toward insulin

In a groundbreaking moment in 1889, two German scientists, Joseph von Mering and Oskar Minkowski, uncovered a crucial link between the pancreas and diabetes through an unexpected laboratory observation. After removing a dog's pancreas, they discovered sugar in its urine, prompting a pivotal shift from merely addressing symptoms of the…

The Economic Times

Get all your
news in one place.

100's of premium titles.
One news app.

Medical Daily

With Nation's Highest Diabetes Rate, San Antonio Faces Major Shift as Medicare Prepares $50 Wegovy Coverage

With diabetes rates among the highest in the U.S., San Antonio could see major change as Medicare's new $50 Wegovy coverage begins July 1, expanding access for eligible residents.

Kiplinger

What This Year's Biggest Medicare Changes Mean for You

Some drug prices are falling, other costs are climbing, and new rules abound. Here's what you need to know.

International Business Times

How Zoe Heineman's Lifelong Fight for Diabetes Access Led Her to The Intersection of Healthcare Research & AI

The economic impact of diabetes continues to be significant. It is estimated that diagnosed diabetes generated approximately $413 billion in total costs in the United States, including direct medical expenses and indirect costs associated with lost productivity.

Medical Daily

From Crisis to Possible Cure Path: San Antonio Battles Highest Diabetes Rates as Wegovy and Medicare (United States) Expansion Offer New Hope

Diabetes care is entering a new era in San Antonio as the Wegovy pill and expanded Medicare coverage offer new hope for preventing and managing diabetes in one of America's hardest-hit cities.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Why insulin, the core element of diabetes treatment remains inaccessible for millions of people

The discovery of insulin in 1921 revolutionised diabetes care. Type 1 diabetes went from being a death sentence to a manageable chronic condition.

AAP

ERA Congress: Semaglutide linked to better quality of life in diabetes and kidney disease, FLOW trial shows

GLASGOW, Scotland, June 4, 2026 /PRNewswire/ -- New findings from the landmark FLOW trial, presented at the 63rd ERA Congress, show that once-weekly semaglutide significantly improved health-related quality of life in adults with type 2 diabetes (T2D) and chronic kidney disease (CKD), equivalent to around eight additional days in full…

MarketBeat

MiniMed Group Q4 Earnings Call Highlights

MiniMed Group (NASDAQ:MMED) reported record fiscal 2026 revenue and outlined a slate of product launches it said will support faster growth in fiscal 2027, as management held the company’s first earnings call as a standalone public company following its March IPO. Chief Executive Officer Que Dallar

MarketBeat

Medtronic Q4 Earnings Call Highlights

Medtronic (NYSE:MDT) reported what executives described as its strongest top-line performance in a decade, as growth in cardiac ablation, diabetes, medical-surgical products and select neuroscience platforms helped drive fiscal fourth-quarter and full-year results above expectations. Chairman and C

The Economic Times

Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight loss

Alkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordable for diabetes and obesity management. The company is the first in India to offer this convenient format. This move intensifies competition in the growing Indian drug market. Alkem aims to expand access…

The Conversation

GLP-1 drugs like Ozempic show promise for more than weight loss. But what’s science vs hype?

You’ve probably heard of Ozempic or Wegovy. These are the injectable drugs that have become household names for weight loss and diabetes.

The Economic Times

The supplement your doctor hasn't mentioned yet could be quietly fighting type 2 diabetes - here's everything you need to know

Fish oil benefits for type 2 diabetes: Fish oil supplementation reduced insulin resistance and improved glucose tolerance in non-obese diabetic rats, suggesting inflammation plays a key role even without excess weight. Omega-3 fatty acids shifted immune cells towards an anti-inflammatory state, potentially improving metabolic health.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Immigration and Customs Enforcement

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.